Botox battle lands in Texas court
A French biopharma group has asked a US court to enforce an ICC award that restrains its Swiss partner Galderma from independently obtaining regulatory approval for a novel Botox treatment.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.